Coley's lessons remembered: augmenting mistletoe therapy
M Orange, U Reuter, U Hobohm - Integrative Cancer …, 2016 - journals.sagepub.com
The following four observations point in the same direction, namely that there is an
unleveraged potential for stimulating the innate immune system against cancer:(1) …
unleveraged potential for stimulating the innate immune system against cancer:(1) …
Durable regression of primary cutaneous B-cell lymphoma following fever-inducing mistletoe treatment: two case reports
M Orange, A Lace, MP Fonseca… - Global Advances in …, 2012 - journals.sagepub.com
Background: Mistletoe is a complementary cancer treatment that is widely used, usually in
addition to and alongside recommended conventional cancer therapy. However, little is …
addition to and alongside recommended conventional cancer therapy. However, little is …
[HTML][HTML] Simple and effective bacterial-based intratumoral cancer immunotherapy
CSE Carroll, ER Andrew, L Malik, KF Elliott… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background We describe intratumoral injection of a slow-release emulsion of killed
mycobacteria (complete Freund's adjuvant (CFA)) in three preclinical species and in human …
mycobacteria (complete Freund's adjuvant (CFA)) in three preclinical species and in human …
[PDF][PDF] Mistletoe therapy for cancer patients
M Orange - 2011 - element7wellness.com
Mobilising the host's innate defences against established cancer and residual disease is an
attractive and rational therapeutic approach. However, tumours have robust mechanisms …
attractive and rational therapeutic approach. However, tumours have robust mechanisms …
Complete, Durable Remission of Advanced Hepatocellular Carcinoma under Treatment with Viscum album Extracts: A Case Report
M Orange, N Poidimani, A Crosignani… - Complementary …, 2022 - karger.com
Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths.
Early-stage disease is treated with curative intent, but most patients present with advanced …
Early-stage disease is treated with curative intent, but most patients present with advanced …
LONG-TIME SURVIVAL (48 MONTHS) IN A PATIENT WITH METASTATIC MYXOFIBROSARCOMA UNDER INTEGRATIVE CANCER CARE: SYSTEMIC THERAPY …
D GIGINEISHVILI, T GIGINEISHVILI… - Experimental and …, 2023 - journals.4science.ge
Myxofibrosarcoma (MFS) is a rare cancer starting in the connective tissue and growing in
arm or leg. High grade MFS spreads quickly and has a poor prognosis. Management of …
arm or leg. High grade MFS spreads quickly and has a poor prognosis. Management of …
[CITATION][C] The role of intralesional mistletoe application in the treatment of breast cancer. Three case-reports
B Maris, M Orange - Phytomedicine, 2015 - infona.pl
The role of intralesional mistletoe application in the treatment of breast cancer. Three case-reports
× Close The Infona portal uses cookies, ie strings of text saved by a browser on the user's …
× Close The Infona portal uses cookies, ie strings of text saved by a browser on the user's …
[BOOK][B] ALIENATION AND SELF-ESTEEM AS THEY RELATE TO RACE, SEX, SOCIOECONOMIC ANDSCHOOL VARIABLES IN URBAN HIGH SCHOOL AGE …
MO White - 1968 - search.proquest.com
Implications................................... 138 VI. SUMMARY AND CONCLUSIONS...............................
143* Procedure...................................... 145 Analysis......................................... 145 Results …
143* Procedure...................................... 145 Analysis......................................... 145 Results …
[CITATION][C] Reconceptualising toddler aggression: a thesis presented in partial fulfilment of the requirements for the degree of Master of Education at Massey …
CM Orange - 2005 - Massey University
[CITATION][C] Mistletoe Therapy for Cancer Patients
O Maurice - A thesis for the degree of Master of Science in Clinical …, 2010